|
Tweet | ||
664 * ! | Thu, 8/13/2015, 10:30 AM - 12:20 PM | CC-608 | |
Making Better Decisions in Cancer Research: Accelerating Statistical Innovation — Invited Papers | |||
Biopharmaceutical Section , International Chinese Statistical Association , Biometrics Section | |||
Organizer(s): Satrajit Roychoudhury, Novartis Pharmaceuticals | |||
Chair(s): Satrajit Roychoudhury, Novartis Pharmaceuticals | |||
10:35 AM | New Developments in Biomarker-Based Oncology Trial Design — Daniel Sargent, Mayo Clinic | ||
10:55 AM | An Audit Strategy for Blinded Independent Central Review of Progression in Cancer Clinical Trials Using Bayesian Predictive Model — Soumi Lahiri, Novartis Pharmaceuticals ; Satrajit Roychoudhury, Novartis Pharmaceuticals | ||
11:15 AM | Statistical Challenges in Oncology Clinical Trials in the Era of Targeted Therapy — Rajeshwari Sridhara, FDA | ||
11:35 AM | Incorporating the SMART Design into Oncology: Overcoming Challenges to Reap the Benefits — Kelley McLain Kidwell, University of Michigan | ||
11:55 AM | Discussant: Pandurang M. Kulkarni, Eli Lilly and Company | ||
12:15 PM | Floor Discussion |
For program information, contact the JSM Registration Department or phone (888) 231-3473.
For Professional Development information, contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
2015 JSM Online Program Home
ASA Meetings Department
732 North Washington Street, Alexandria, VA 22314
(703) 684-1221 • meetings@amstat.org
Copyright © American Statistical Association.